Showing results (921-930 of 6,317) with videos related to

Sort By:
Pageof 632
Diabetes, Obesity & Metabolism|April 12, 2019
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trialsIlaria Dicembrini, Besmir Nreu, Edoardo Mannucci, et al.
Diabetes, Obesity & Metabolism|May 14, 2019
A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium-glucose co-transporter-2 inhibitorsEmily Brown, Surya P Rajeev, Daniel J Cuthbertson, et al.
Diabetes, Obesity & Metabolism|April 18, 2019
Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoringJeremy Pettus, Jasvinder Gill, Sachin Paranjape, et al.
Diabetes, Obesity & Metabolism|October 20, 2021
Cardiovascular risk profiles: A cross-sectional study evaluating the generalizability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials REWIND, LEADER and SUSTAIN-6 to the real-world type 2 diabetes population in the United KingdomJoanne Webb, Julie Mount, Lill-Brith von Arx, et al.
Diabetes, Obesity & Metabolism|July 9, 2019
Association between blood pressure variability, cardiovascular disease and mortality in type 2 diabetes: A systematic review and meta-analysisMartina Chiriacò, Konstantinos Pateras, Agostino Virdis, et al.
Diabetes, Obesity & Metabolism|October 26, 2021
A model-based simulation of glycaemic control and body weight when switching from semaglutide to 3.0- and 4.5-mg doses of once-weekly dulaglutideLai San Tham, Kevin M Pantalone, Kathleen Dungan, et al.
Diabetes, Obesity & Metabolism|March 8, 2022
Changes over time in the cardiovascular risk profile of type 2 diabetes from 2007 to 2020: A community-based studyBrent A Williams, Jonathan P Brady, Stephen Voyce, et al.
Diabetes, Obesity & Metabolism|March 8, 2022
Integrated metagenomics and metabolomics analysis illustrates the systemic impact of the gut microbiota on host metabolism after bariatric surgeryYeyoung Han, Gihyeon Kim, Eunyong Ahn, et al.
Diabetes, Obesity & Metabolism|March 10, 2022
Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin-treated type 2 diabetes: Results from a real-world nested case-control studyJulie Settles, Hong Kan, Christopher J Child, et al.
Diabetes, Obesity & Metabolism|March 10, 2022
Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose-lowering agent: An analysis from VERTIS CVSamuel Dagogo-Jack, Christopher P Cannon, David Z I Cherney, et al.
Pageof 632